Amping up T cells to target cancer
محرر واقع مصر
إم آي تي تكنولوجي ريفيو
25 أغسطس, 2026
Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening it—delivering the vaccine along with immune-stimulating molecules called cytokines—can…
